Baidu
map

Cytokine:中国汉族人口中,与过敏性疾病位点和儿童过敏性鼻炎相关的16个全基因组关联研究相关性分析

2018-09-10 AlexYang MedSci原创

过敏性鼻炎(AR)是儿童中最常见的呼吸道疾病之一。它是由遗传因素和环境因素组合引起的。中度到重度AR能够降低儿童的生活品质和社交表现。最近,有研究人员调查了是否已经报道的全基因组关联研究(GWAS)中的过敏性疾病位点的多样性与汉族儿童AR和AR症状严重度相关。研究发现,在EMSY区域,与AA和CC基因型相比,rs7130588_AG和rs7927894_CT与AR风险的显著增加相关(分别vie为1

过敏性鼻炎(AR)是儿童中最常见的呼吸道疾病之一。它是由遗传因素和环境因素组合引起的。中度到重度AR能够降低儿童的生活品质和社交表现。最近,有研究人员调查了是否已经报道的全基因组关联研究(GWAS)中的过敏性疾病位点的多样性与汉族儿童AR和AR症状严重度相关。研究发现,在EMSY区域,与AA和CC基因型相比,rs7130588_AG和rs7927894_CT均与AR风险的显著增加相关(分别为1.75倍和1.50倍),特别是在中度到重度AR中更具有特异性。在调整错误发现率(FDR)且调整后风险比1.818和95%置信区间(CI)为1.240-2.664(PFDR=0.0349)后,在多重校正加性模型中,rs7130588基因型在案例和对照中的差异仍旧具有统计学显著性。rs7130588_G等位基因只与高风险中度到重度AR相关(1.85-fold, Page and gender_adjustment=0.003)。与TT基因型相比,在IL4位点的rs2227284_TG基因型与AR风险0.65倍的减少显著相关。 研究人员同样发现了rs2227284_G等位基因在不同严重度AR中的保护性作

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2069431, encodeId=e3782069431bb, content=<a href='/topic/show?id=c4ad28491a8' target=_blank style='color:#2F92EE;'>#儿童过敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28491, encryptionId=c4ad28491a8, topicName=儿童过敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Dec 25 15:40:00 CST 2018, time=2018-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754032, encodeId=ad901e5403244, content=<a href='/topic/show?id=dd6f2849351' target=_blank style='color:#2F92EE;'>#儿童过敏性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28493, encryptionId=dd6f2849351, topicName=儿童过敏性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aff136654610, createdName=charl1234579, createdTime=Thu Jul 11 15:40:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837562, encodeId=169b183e562a0, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sun Dec 09 00:40:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047017, encodeId=0031204e01755, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Apr 18 09:40:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342212, encodeId=78201342212ae, content=<a href='/topic/show?id=62eb2939954' target=_blank style='color:#2F92EE;'>#全基因组关联研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29399, encryptionId=62eb2939954, topicName=全基因组关联研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523609, encodeId=d16315236096a, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546498, encodeId=24bc15464988a, content=<a href='/topic/show?id=81eb2939373' target=_blank style='color:#2F92EE;'>#全基因组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29393, encryptionId=81eb2939373, topicName=全基因组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc2113925052, createdName=ms1692810954239974, createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=)]
    2018-12-25 zutt
  2. [GetPortalCommentsPageByObjectIdResponse(id=2069431, encodeId=e3782069431bb, content=<a href='/topic/show?id=c4ad28491a8' target=_blank style='color:#2F92EE;'>#儿童过敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28491, encryptionId=c4ad28491a8, topicName=儿童过敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Dec 25 15:40:00 CST 2018, time=2018-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754032, encodeId=ad901e5403244, content=<a href='/topic/show?id=dd6f2849351' target=_blank style='color:#2F92EE;'>#儿童过敏性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28493, encryptionId=dd6f2849351, topicName=儿童过敏性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aff136654610, createdName=charl1234579, createdTime=Thu Jul 11 15:40:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837562, encodeId=169b183e562a0, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sun Dec 09 00:40:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047017, encodeId=0031204e01755, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Apr 18 09:40:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342212, encodeId=78201342212ae, content=<a href='/topic/show?id=62eb2939954' target=_blank style='color:#2F92EE;'>#全基因组关联研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29399, encryptionId=62eb2939954, topicName=全基因组关联研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523609, encodeId=d16315236096a, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546498, encodeId=24bc15464988a, content=<a href='/topic/show?id=81eb2939373' target=_blank style='color:#2F92EE;'>#全基因组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29393, encryptionId=81eb2939373, topicName=全基因组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc2113925052, createdName=ms1692810954239974, createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2069431, encodeId=e3782069431bb, content=<a href='/topic/show?id=c4ad28491a8' target=_blank style='color:#2F92EE;'>#儿童过敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28491, encryptionId=c4ad28491a8, topicName=儿童过敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Dec 25 15:40:00 CST 2018, time=2018-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754032, encodeId=ad901e5403244, content=<a href='/topic/show?id=dd6f2849351' target=_blank style='color:#2F92EE;'>#儿童过敏性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28493, encryptionId=dd6f2849351, topicName=儿童过敏性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aff136654610, createdName=charl1234579, createdTime=Thu Jul 11 15:40:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837562, encodeId=169b183e562a0, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sun Dec 09 00:40:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047017, encodeId=0031204e01755, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Apr 18 09:40:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342212, encodeId=78201342212ae, content=<a href='/topic/show?id=62eb2939954' target=_blank style='color:#2F92EE;'>#全基因组关联研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29399, encryptionId=62eb2939954, topicName=全基因组关联研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523609, encodeId=d16315236096a, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546498, encodeId=24bc15464988a, content=<a href='/topic/show?id=81eb2939373' target=_blank style='color:#2F92EE;'>#全基因组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29393, encryptionId=81eb2939373, topicName=全基因组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc2113925052, createdName=ms1692810954239974, createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2069431, encodeId=e3782069431bb, content=<a href='/topic/show?id=c4ad28491a8' target=_blank style='color:#2F92EE;'>#儿童过敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28491, encryptionId=c4ad28491a8, topicName=儿童过敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Dec 25 15:40:00 CST 2018, time=2018-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754032, encodeId=ad901e5403244, content=<a href='/topic/show?id=dd6f2849351' target=_blank style='color:#2F92EE;'>#儿童过敏性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28493, encryptionId=dd6f2849351, topicName=儿童过敏性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aff136654610, createdName=charl1234579, createdTime=Thu Jul 11 15:40:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837562, encodeId=169b183e562a0, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sun Dec 09 00:40:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047017, encodeId=0031204e01755, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Apr 18 09:40:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342212, encodeId=78201342212ae, content=<a href='/topic/show?id=62eb2939954' target=_blank style='color:#2F92EE;'>#全基因组关联研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29399, encryptionId=62eb2939954, topicName=全基因组关联研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523609, encodeId=d16315236096a, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546498, encodeId=24bc15464988a, content=<a href='/topic/show?id=81eb2939373' target=_blank style='color:#2F92EE;'>#全基因组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29393, encryptionId=81eb2939373, topicName=全基因组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc2113925052, createdName=ms1692810954239974, createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2069431, encodeId=e3782069431bb, content=<a href='/topic/show?id=c4ad28491a8' target=_blank style='color:#2F92EE;'>#儿童过敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28491, encryptionId=c4ad28491a8, topicName=儿童过敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Dec 25 15:40:00 CST 2018, time=2018-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754032, encodeId=ad901e5403244, content=<a href='/topic/show?id=dd6f2849351' target=_blank style='color:#2F92EE;'>#儿童过敏性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28493, encryptionId=dd6f2849351, topicName=儿童过敏性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aff136654610, createdName=charl1234579, createdTime=Thu Jul 11 15:40:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837562, encodeId=169b183e562a0, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sun Dec 09 00:40:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047017, encodeId=0031204e01755, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Apr 18 09:40:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342212, encodeId=78201342212ae, content=<a href='/topic/show?id=62eb2939954' target=_blank style='color:#2F92EE;'>#全基因组关联研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29399, encryptionId=62eb2939954, topicName=全基因组关联研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523609, encodeId=d16315236096a, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546498, encodeId=24bc15464988a, content=<a href='/topic/show?id=81eb2939373' target=_blank style='color:#2F92EE;'>#全基因组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29393, encryptionId=81eb2939373, topicName=全基因组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc2113925052, createdName=ms1692810954239974, createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2069431, encodeId=e3782069431bb, content=<a href='/topic/show?id=c4ad28491a8' target=_blank style='color:#2F92EE;'>#儿童过敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28491, encryptionId=c4ad28491a8, topicName=儿童过敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Dec 25 15:40:00 CST 2018, time=2018-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754032, encodeId=ad901e5403244, content=<a href='/topic/show?id=dd6f2849351' target=_blank style='color:#2F92EE;'>#儿童过敏性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28493, encryptionId=dd6f2849351, topicName=儿童过敏性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aff136654610, createdName=charl1234579, createdTime=Thu Jul 11 15:40:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837562, encodeId=169b183e562a0, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sun Dec 09 00:40:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047017, encodeId=0031204e01755, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Apr 18 09:40:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342212, encodeId=78201342212ae, content=<a href='/topic/show?id=62eb2939954' target=_blank style='color:#2F92EE;'>#全基因组关联研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29399, encryptionId=62eb2939954, topicName=全基因组关联研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523609, encodeId=d16315236096a, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546498, encodeId=24bc15464988a, content=<a href='/topic/show?id=81eb2939373' target=_blank style='color:#2F92EE;'>#全基因组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29393, encryptionId=81eb2939373, topicName=全基因组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc2113925052, createdName=ms1692810954239974, createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2069431, encodeId=e3782069431bb, content=<a href='/topic/show?id=c4ad28491a8' target=_blank style='color:#2F92EE;'>#儿童过敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28491, encryptionId=c4ad28491a8, topicName=儿童过敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Dec 25 15:40:00 CST 2018, time=2018-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754032, encodeId=ad901e5403244, content=<a href='/topic/show?id=dd6f2849351' target=_blank style='color:#2F92EE;'>#儿童过敏性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28493, encryptionId=dd6f2849351, topicName=儿童过敏性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aff136654610, createdName=charl1234579, createdTime=Thu Jul 11 15:40:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837562, encodeId=169b183e562a0, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sun Dec 09 00:40:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047017, encodeId=0031204e01755, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Apr 18 09:40:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342212, encodeId=78201342212ae, content=<a href='/topic/show?id=62eb2939954' target=_blank style='color:#2F92EE;'>#全基因组关联研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29399, encryptionId=62eb2939954, topicName=全基因组关联研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523609, encodeId=d16315236096a, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546498, encodeId=24bc15464988a, content=<a href='/topic/show?id=81eb2939373' target=_blank style='color:#2F92EE;'>#全基因组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29393, encryptionId=81eb2939373, topicName=全基因组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc2113925052, createdName=ms1692810954239974, createdTime=Wed Sep 12 01:40:00 CST 2018, time=2018-09-12, status=1, ipAttribution=)]

相关资讯

Ear Nose Throat J:在季节过敏性鼻炎中,孟鲁司特作为一种预防性治疗效果研究

在季节过敏性鼻炎中,能够支持花粉季节开始之前进行预防性治疗的证据仍旧很少。最近,有研究人员进行了一项研究,调查了孟鲁司特对季节过敏性鼻炎预防治疗的效果,并且评估了对下呼吸道炎症情况的影响。研究群体包括了57名成年人,并被随机分配到了预防性治疗组和对照组。预防性治疗组包括了31名患者(10名男性和21名女性,年龄在18到54岁之间(平均年龄为36.9岁))。预防性治疗组接受孟鲁司特治疗,在柏树花粉季

Allergy:中国艾属花粉过敏研究

在中国北部,艾属花粉过敏是哮喘重要的过敏原。lgE对艾属花粉过敏原组分的响应与临床表型之间的可能相关性还没有评估。最近,有研究人员建立了4种艾属花粉过敏原的敏感模式,并在中国3个地区探究了与人口特性和临床表型之间可能的相关性。研究包括了240名对艾属花粉过敏的患者,其中178名来自陕西省,30名来自山东省,32名赖在云南省。研究人员诊断了过敏性哮喘、鼻炎、结膜炎和湿疹症状。所有患者的血清通过Imm

Allergol Int:在季节过敏性鼻炎中,全唾液在舌下免疫治疗效果中的作用研究

开发能够预测舌下免疫治疗(SLIT)治疗过敏性疾病临床效果的方法是一个非常关键的问题。全唾液作为SLIT治疗中与过敏原提取物首先接触的组分,最近,有研究人员在日本柳杉花粉过敏症中,探究了是否全唾液与SLIT的临床效果相关。研究人员将血液单核细胞或者单核THP-1细胞培养在含有或者不含油全唾液或者纯唾液的培养基中,并且还包括或者不包括唾液过滤和TLR2和/或TLR4信号的阻断处理。研究发现,单核细胞

Oncol Lett:在过敏性鼻炎中,线粒体ROS能够激活白介素-1β的表达

过敏性鼻炎(AR)是鼻粘膜炎症最常见的起因。同样也是最常见的非传染性鼻炎,并且与免疫球蛋白E(lgE)介导的过敏原免疫响应有关。之前的研究表明了白介素-1β在过敏性哮喘的发展过程中具有病理作用。最近,有研究人员评估了是否IL-1β参与了AR的发病机理过程。研究总共包括了45名患有AR的患者,并且他们的外周血单个核细胞(PBMCs)中IL-1β表达增加;并且在AR患者中,单核细胞/巨噬细胞和PBMC

Allergy:SQ屋尘螨舌下免疫治疗药片疗效和安全性研究

SQ屋尘螨(HDM)舌下免疫治疗(SLIT)药片治疗在治疗年龄不小于12岁患者的呼吸道过敏性疾病中是有效的。最近,有研究人员调查了上述治疗方法在日本5-17岁患有中度到重度HMD过敏性鼻炎(AR)患者中的效果和安全性。研究是一个随机、双盲和安慰剂对照实验,458名日本儿童随机分配到治疗组和安慰剂对照组,进行为期1年的治疗和调查。研究的主要结果是治疗结束前8周的总的组合鼻炎得分(TCRS),包括AR

Eur Arch Otorhinolaryngol:小檗碱和辅酶Q10对卵清蛋白诱导的过敏性鼻炎的改善作用研究

小檗碱和辅酶Q10(CoQ10)具有抗炎症和抗氧化特性。最近,有研究人员调查了小檗碱和辅酶Q10对过敏性鼻炎的有益影响。研究包括了30只斯普拉格-杜勒鼠,并通过卵清蛋白来建立过敏性鼻炎模型。研究人员将小鼠随机分成5个组,并对每个组进行不同的处理,并利用组织病理学免疫组织化学检查对小鼠鼻组织进行了分析。研究发现,在诱导过敏性鼻炎小鼠中,鼻症状得分、血清免疫球蛋白E、IL-4、IL-13、MDA和NO

Baidu
map
Baidu
map
Baidu
map